عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
 
 
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

NCR graphs - Age specific incidence rates

- All cancer age-specific incidence rates, including non-melanoma skin cancer, males, Lebanon, 2009, 2014, 2019, 2024
- All cancer age-specific incidence rates, including non-melanoma skin cancer, females, Lebanon, 2009, 2014, 2019, 2024

- All cancer age-specific incidence rates, excluding non-melanoma skin cancer, males, Lebanon, 2009, 2014, 2019, 2024
- All cancer age-specific incidence rates, excluding non-melanoma skin cancer, females, Lebanon, 2009, 2014, 2019, 2024

- Oesophagus cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Oesophagus cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Estomac cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Estomac cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Colo-rectal cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Colo-rectal cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Liver cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Liver cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Pancreas cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Pancreas cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Larynx cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Larynx cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Trachea-bronchus-lung cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Trachea-bronchus-lung cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Melanoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Melanoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Non-melanoma skin cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Non-melanoma skin cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Breast cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Breast cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Col uteri cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
- Corpus uteri cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
- Ovary cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Prostate cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024

- Kidney cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Kidney cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Bladder cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Bladder cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Brain and central nervous system cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Brain and central nervous system cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Thyroid cancer age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Thyroid cancer age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Hodgkin's lymphoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Hodgkin's lymphoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Non-Hodgkin lymphoma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Non-Hodgkin lymphoma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Multiple Myeloma age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Multiple Myeloma age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Lymphoid leukemia age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Lymphoid leukemia age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024

- Myeloid leukemia age-specific incidence rates, males, Lebanon, 2009, 2014, 2019, 2024
- Myeloid leukemia age-specific incidence rates, females, Lebanon, 2009, 2014, 2019, 2024
 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution+diluent 830,623 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution+diluent 7,236,698 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 2g, Tazobactam (sodium) - 0.25g Injectable powder for solution 830,623 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 997,259 L.L
J01CR05 YANOVEN G Piperacillin (sodium) - 4g, Tazobactam (sodium) - 0.5g Injectable powder for solution 10,860,623 L.L
G03AA12 YASMIN B Drospirenone - 3mg, Ethinylestradiol - 30mcg Tablet, film coated 616,824 L.L
N06DA02 YASNAL Q-TAB G Donepezil - 10mg 10mg Tablet, orodispersible 1,376,095 L.L
N06DA02 YASNAL Q-TAB G Donepezil - 5mg 5mg Tablet, orodispersible 1,376,095 L.L
G03AA12 YAZ B Drospirenone - 3mg, Ethinylestradiol - 20mcg Tablet, film coated 1,177,206 L.L
J07BL01 YELLOW FEVER VACCINE, LIVE, FREEZE DRIED BioTech Yellow Fever virus, 17D strain - no less than 1600PFU/0.5ml Injectable lyophilisate for solution 3,527,587 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution 332,262,937 L.L
L01CX01 YONDELIS B Trabectedin - 1mg 1mg Injectable powder for solution 126,536,515 L.L
R03BB08 YUPELRI B Revefenacin - 175mcg/3ml 175mcg/3ml Inhalation solution 3,104,276 L.L
Sitemap
© Copyrights reserved to Ministry of Public Health 2026